BioNexus Gene Lab Corp. (Nasdaq: BGLC) advances precision diagnostics and AI-enabled health technologies to make next-generation testing accessible, affordable, and actionable throughout Southeast ...
Investing.com -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) stock surged 10% following the announcement of strategic agreements with Fidelion Diagnostics to commercialize VitaGuard, a liquid biopsy ...
InvestorsHub on MSN
BioNexus Gene Lab Shares Surge on Strategic MRD Testing Partnership
BioNexus Gene Lab Corp. (NASDAQ:BGLC) shares jumped 10% after the company announced strategic agreements with Fidelion Diagnostics to jointly commercialize VitaGuard, a next-generation liquid biopsy ...
Unlock the secrets to growing your own giant pumpkin with expert tips, genetic insights, and community support. Join the ...
According to the 13F filing with the Securities and Exchange Commission dated Nov. 12, 2025, ARK Investment Management sold 395,617 shares of CRISPR Therapeutics AG during the third quarter. Its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback